Greco Theresa 4
4 · OptimizeRx Corp · Filed Nov 3, 2023
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Greco Theresa
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-11-01+18,519→ 37,038 total - Award
Stock Option
2023-11-01+35,758→ 35,758 totalExercise: $8.10Exp: 2028-11-01→ Common Stock (35,758 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on November 1, 2024, which is the first anniversary of the date of grant.
- [F2]The stock option vests in three equal annual installments beginning November 1, 2024, the first anniversary of the grant date.